Amended Securities Registration (section 12(b)) (8-a12b/a)
June 01 2016 - 4:51PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A/A
Amendment No. 1
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
AURIS MEDICAL HOLDING AG
(Exact Name of Registrant as Specified in
Its Charter)
Switzerland
(State of Incorporation or Organization)
|
Not Applicable
(I.R.S. Employer Identification No.)
|
|
|
Bahnhofstrasse 21
|
|
|
|
Zug, Switzerland
(Address of Principal Executive Offices)
|
6300
(Zip Code)
|
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
|
Title of Each Class
to be so Registered
|
Name of Each Exchange on Which
Each Class is to be Registered
|
Common shares, nominal value CHF 0.40 per share
|
The NASDAQ Stock Market LLC
|
Common shares, nominal value CHF 0.40 per share The NASDAQ
Stock Market LLC
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒:
|
|
|
|
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐
|
|
|
|
Securities Act registration statement file number to which this form relates:
|
333-197105
(If applicable)
|
|
|
Securities to be registered pursuant to Section 12(g) of the Act:
|
|
|
|
(Title of Class)
|
N/A
INFORMATION REQUIRED IN REGISTRATION
STATEMENT
This Amendment No. 1 to Form 8-A amends
and supplements the information set forth in the Registration Statement on Form 8-A filed by the Registrant with the Securities
and Exchange Commission (the “Commission”) on July 29, 2014.
Item 1: Description of Registrant’s Securities
to be Registered
The description under the heading “Description
of Share Capital and Articles of Association” relating to the Registrant’s common shares, CHF 0.40 nominal value per
share (the “Common Shares”), in the Registrant’s prospectus supplement relating to the Registrant’s Registration
Statement on Form F-3 (Registration No. 333-206710) filed with the Securities and Exchange Commission on June 1, 2016 pursuant
to Rule 424(b) under the Securities Act of 1933, as amended, is incorporated by reference herein.
Item 2: Exhibits
Pursuant to the Instructions as to Exhibits
with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on
The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
Auris Medical Holding AG
|
By:
|
/s/ Thomas Meyer
|
|
Name:
|
Thomas Meyer
|
|
Title:
|
Chief Executive Officer
|
Date: June 1, 2016
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Oct 2023 to Oct 2024